soul trial oral semaglutide cardiovascular outcomes nejm 2025 results Presented at ACC.25: Among participants with type 2 diabetes and disease, chronic kidney disease, or both, (14 mg) was associated with a lower risk of cardiovascular events than placebo soul trial oral semaglutide cardiovascular

These shifts in insulin response correspond with improved therapeutic outcomes

The diagnostic accuracy, analyzed using the receiver operating characteristic (ROC), showed 93% specificity and 40% sensitivity (area under the curve (AUC) = 0.72) for glutarylcarnitine

Functional inactivation of the IGF-I and insulin receptors in skeletal muscle causes type 2 diabetes

Clark SM, Di Leo R, Dhanoa PK, Van Cauwenberghe OR, Mullen RT, Shelp J (2009) Biochemical characterization, mitochondrial localization, expression, and potential functions for an Arabidopsis -aminobutyrate transaminase that utilizes both pyruvate and glyoxylate

Helps in reducing fine lines, wrinkles & signs of aging

Providing your body with targeted GLP-1 vitamin support ensures your metabolism has the tools it needs to function